Jim Simons's position in Alpine Immune Sciences is currently worth $14 Million. That's 0.02% of their equity portfolio (770th largest holding). The first Alpine Immune Sciences trade was made in Q3 2017. Since then Jim Simons bought shares thirteen more times and sold shares on twelve occasions. The stake costed the investor $1.74 Million, netting the investor a gain of 704% so far.